English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 45422/58598 (78%)
造訪人次 : 2514710      線上人數 : 156
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧：
  • 您可在西文檢索詞彙前後加上"雙引號"，以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋，建議至進階搜尋限定作者欄位，可獲得較完整資料
    •  進階搜尋


    請使用永久網址來引用或連結此文件: http://libir.tmu.edu.tw/handle/987654321/4948


    題名: Rosiglitazone 透過 ERK-1/-2 信息傳遞路徑誘導腎臟環間膜細胞之分化
    ERK-1/-2 Dependent Induction of Mesangial Cell Differentiation by Rosiglitazone
    作者: 陳怡如
    Yu-Ju Chen
    貢獻者: 醫學檢驗暨生物技術學研究所
    關鍵詞: rosiglitazone
    分化
    腎臟環間膜細胞
    p44/42 MAPK
    PPAR gamma
    rosiglitazone
    differentiation
    mesangial cell
    p44/42 MAPK
    PPAR gamma
    日期: 2003
    上傳時間: 2009-09-10 17:21:33 (UTC+8)
    摘要: Rosiglitazone是一種peroxisome proliferator-activated receptor-gamma (PPAR-g agonist，在第二型糖尿病的實驗模式中被認為能夠減少 mesangium 的過度增生。本研究中發現，在大鼠腎臟環間膜細胞中給予PPAR-g agonist時，會調控大鼠腎臟環間膜細胞增生。當以rosiglitazone刺激大鼠腎臟環間膜細胞時，發現會造成活細胞數目與DNA合成的減少，並使得CDK 抑制劑--p21cip1的表現增加，進而造成細胞生長停滯。此外，rosiglitazone 也會增加大鼠腎臟環間膜細胞PDK-1、protein kinase B/Akt (PKB/Akt) Serine473 磷酸化與 Akt kinase的活性。而這些反應會被phosphatidylinositol 3-kinase (PI3-K)的抑制劑--LY294002 與 wortmannin 所抑制。而rosiglitazone 會使腎臟環間膜細胞分化的指標-- smooth muscle a-actin (SMA) 的表現增加。由於LY294002 與 wortmannin 並無法抑制 SMA 的表現，所以SMA 表現可能不是經由PI3-K 的信息傳遞路徑而來的。但是SMA 表現可以被protein tyrosine kinase的抑制劑--genistein 與 MEK 的抑制劑--PD98059所抑制。因此，推測 SMA 表現可能是透過protein tyrosine kinase-MEK-mitogen-activated protein kinase 的信息傳遞路徑來調控大鼠腎臟環間膜細胞的分化。這些結果證明了PPAR-g 透過 Erk 的傳遞路徑，扮演了調控腎臟環間膜細胞的分化的機制。
    Rosiglitazone is a peroxisome proliferator-activated receptor-gamma (PPAR-g) agonist that has been shown to halt mesangium expansion in experimental models of type 2 diabetes mellitus. In the present study, rat mesangial cells were treated with rosiglitazone and its molecular mechanisms coupling growth arrest were examined. Treatment of rat mesangial cells with rosiglitazone resulted in reduction of viable cells and inhibition of [3H] thymidine incorporation. Treatment with rosiglitazone increased the expression of CDK inhibitor, p21CIP-1, which was associated with cell cycle arrest. Rosiglitazone increased PDK-1 and protein kinase B/Akt (PKB/Akt) Serine473 phosphorylation and Akt kinase activity in rat mesangial cells, and these responses were inhibited with the pharmacological inhibitor of phosphatidylinositol 3-kinase (PI3-K), LY294002 or wortmannin. Rosiglitazone increased the expression of smooth muscle a-actin (SMA), a differentiation marker for mesangial cells. LY294002 or wortmannin pretreated cells failed to blocked SMA expression suggesting SMA expression is not mediated through PI3-K dependent pathway. The expression of SMA was inhibited by genistein (a protein tyrosine kinase inhibitor), by PD98059 (a MEK inhibitor), suggesting protein tyrosine kinase-MEK-mitogen-activated protein kinase pathway mediates the differentiation of renal glomerular mesangial cells. These data demonstrate a role for PPAR-g in mediating a molecular mechanism coupling growth arrest and mesangial cell differentiation.
    資料類型: thesis
    顯示於類別:[醫學檢驗暨生物技術學系所] 博碩士論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    摘要.doc28KbMicrosoft Word157檢視/開啟
    摘要.pdf56KbAdobe PDF188檢視/開啟
    摘要.ppt145KbMicrosoft Powerpoint206檢視/開啟
    摘要.ps297KbPostscript79檢視/開啟


    在TMUIR中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    著作權聲明 Copyright Notice

    • 本平台之數位內容為臺北醫學大學所收錄之機構典藏，包含體系內各式學術著作及學術產出。秉持開放取用的精神，提供使用者進行資料檢索、下載與取用，惟仍請適度、合理地於合法範圍內使用本平台之內容，以尊重著作權人之權益。商業上之利用，請先取得著作權人之授權。

      The digital content on this platform is part of the Taipei Medical University Institutional Repository, featuring various academic works and outputs from the institution. It offers free access to academic research and public education for non-commercial use. Please use the content appropriately and within legal boundaries to respect copyright owners' rights. For commercial use, please obtain prior authorization from the copyright owner.

    • 瀏覽或使用本平台，視同使用者已完全接受並瞭解聲明中所有規範、中華民國相關法規、一切國際網路規定及使用慣例，並不得為任何不法目的使用TMUIR。

      By utilising the platform, users are deemed to have fully accepted and understood all the regulations set out in the statement, relevant laws of the Republic of China, all international internet regulations, and usage conventions. Furthermore, users must not use TMUIR for any illegal purposes.

    • 本平台盡力防止侵害著作權人之權益。若發現本平台之數位內容有侵害著作權人權益情事者，煩請權利人通知本平台維護人員([email protected])，將立即採取移除該數位著作等補救措施。

      TMUIR is made to protect the interests of copyright owners. If you believe that any material on the website infringes copyright, please contact our staff([email protected]). We will remove the work from the repository.

    Back to Top
    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋